Revier Therapeutics: Funding, Investors & Team (Aug 2026)
Revier Therapeutics develops small-molecule therapies for cardiometabolic diseases.
Revier Therapeutics has raised $7.0M across 1 funding round on record, the most recent a Seed of $7.0M announced in Aug 2026.
That round is above the $2.3M median round size for Belgium companies tracked on FundedIQ over the last two years.
Revier Therapeutics Company Profile and Key Stats
Latest funding round on record: Aug 2026.
Revier Therapeutics Funding Rounds
Revier Therapeutics Investors
Revier Therapeutics Funding in Context
Revier Therapeutics' latest round of $7.0M is above the median round in Belgium. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Revier Therapeutics in Biotechnology and Deidenberg
Companies Similar to Revier Therapeutics
Motion is an OEM-agnostic Humanoids-as-a-Service (HaaS) platform operator that accelerates the commercial…
MAASH is a biotech mycoprotein producing company that supply a nutritious and health feed and food protein…
Sol.One is a hardwae company that offers flight control, battery MGMT, ground station, comms, and logging…
Relu is a young and driven company that works together with dental.
QuotCraft is an AI-powered SaaS platform that streamlines project management, quoting, and invoicing for…
Endo Tools Therapeutics develops medical devices that provide new means of therapeutic interventions for…
e-peas is a innovative semiconductor company that specializes in creating low-power circuits for connected…
Polysense develops AI-based machine vision software to monitor food production processes, assess quality, and…
Monnett is a social media platform made for humans.
Turning biomass residues into fit-for-purpose microbial fertilizers, biostimulants and biocontrols.
Timefold is a company that offers PlanningAI solutions to help with intricate scheduling and routing…
Adomate is an AI powered advertising platform that helps marketing teams create social media ads at scale.…
Revier Therapeutics Funding FAQs
What does Revier Therapeutics do?
Revier Therapeutics develops small-molecule therapies for cardiometabolic diseases.
How much funding has Revier Therapeutics raised?
Revier Therapeutics has raised $7.0M across 1 round on record. The most recent is a Seed of $7.0M announced in Aug 2026.
When did Revier Therapeutics last raise funding?
Revier Therapeutics' most recent funding round on record is a Seed of $7.0M, announced in Aug 2026.
Who has invested in Revier Therapeutics?
Investors on record for Revier Therapeutics include HTGF (High-Tech Gruenderfonds), KHAN Technology Transfer Fund, VORNvc.
Where is Revier Therapeutics headquartered?
Revier Therapeutics is based in Deidenberg, Belgium.
How many employees does Revier Therapeutics have?
Revier Therapeutics is in the 1-10 employee band.
When was Revier Therapeutics founded?
Revier Therapeutics was founded in 2023.
About FundedIQ's Revier Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Revier Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.